(NaturalNews) When scientific studies found possible biomarkers for cardiovascular disease in recent years, it didn't take long for the medical industry to start manufacturing and promoting blood tests for them, especially the main, supposedly new risk factor for heart disease and stroke known as C-reactive protein (CRP). The claims for CRP testing being important were based on findings it might be a marker of inflammation which leads to heart attacks and strokes. But two new studies just published in the
Journal of the American Medical Association (JAMA) reach conclusions that seem to indicate it is far better to use plain common sense to identify individual
risk factors such as being
overweight, having high blood pressure, smoking tobacco, and not exercising as ways to predict who will have
cardiovascular problems -- not a host of expensive and unproven
tests currently being hyped and promoted by many doctors and medical centers.
Olle Melander, MD, PhD, of Lund University in Sweden, and colleagues assessed a whole list of cardiovascular
biomarkers to see if they were more useful in predicting future cardiovascular events than standard risk factors like hypertension. The study included 5,067 people with an average age of 58 who didn't have signs of
heart disease at the beginning of the study, which recruited patients between 1991 and 1994. The
research subjects were followed until 2006 and the Swedish national hospital discharge and cause-of-death registers were used to see if they had experienced cardiovascular events such as
heart attack, stroke or coronary death.
Many of them had fallen ill to these
health problems. In all, there were over 600 coronary and cardiovascular events experienced during this time. But did expensive biomarker tests turn out to predict who would have one of these events? The use of combinations of biomarkers including
CRP and newer ones dubbed cystatin C, lipoprotein-associated phospholipase 2, midregional proadrenomedullin (MR-proADM), midregional proatrial natriuretic peptide, and N-terminal pro-B-type natriuretic peptide (N-BNP) showed some slight statistical ability to predict who was going to have
heart attacks and stroke, but the finding was very minimal. In fact, the authors wrote, the biomarker testing "did not reclassify a substantial proportion of individuals to higher or lower risk categories". Bottom line: all those tests made no significant difference in figuring out who was at risk and who wasn't.
Another just-published
JAMA study comes down even harder on the idea that CRP tests can predict heart attack and
stroke risk. A group of international
scientists, including researchers from Germany, the United Kingdom and Canada, put together data from several health
studies which had collected DNA from 128,000 research subjects. Headed by epidemiologist Paul Elliott of Imperial College in London, the research team searched for proof that people who have genes known to raise CRP levels have an increased risk of cardiovascular
disease.
But the findings showed that wasn't the case. There have also been claims in previous studies of associations between CRP and type 2 diabetes and even being overweight. But an association is not proof CRP is the
cause of any of these health problems -- nor a cause of heart attacks and strokes.
And there is now no evidence at all CRP testing should be carried out on the masses or that people with elevated CRP need to be treated with new drugs designed to lower it. "Moreover, this study suggests that development of therapeutic strategies targeting specific reductions in plasma levels of CRP are unlikely to be fruitful," the researchers concluded in a statement to the media.
As covered earlier this year in Natural News (
http://www.naturalnews.com/026256_Iceland_health_disease.html), it makes more sense to fight heart disease and stroke with a healthy lifestyle. Research conducted by scientists in
Iceland found, in fact, that between 1981 and 2006 mortality rates from coronary heart disease (CHD) in Iceland plummeted by an amazing 80 percent in men and women between the ages of 25 and 74 due primarily to good nutrition, exercise and other
natural approaches to health.
For more information:http://jama.ama-assn.org/cgi/content/full/302/1/37?homehttp://jama.ama-assn.org/cgi/content/short/302/1/92?homehttp://jama.ama-assn.org/cgi/content/short/302/1/49?home
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Share this article on: 
Now Available from 
